SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending after its recent earnings report, which, despite beating estimates, revealed weak forward guidance and a significant sales decline in China. This has sparked a heated debate among investors, with some viewing the sharp stock drop as an overreaction and a long-term buying opportunity, while others express concerns over product quality, increasing competition from newer brands, and the ongoing impact of tariffs.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investor sentiment surges around its "physical AI" ventures, particularly robotaxis and advanced Full Self-Driving capabilities, which many believe signal the company's next significant growth phase beyond electric vehicles. This narrative fuels an active community debate between those anticipating further upside driven by execution and bears highlighting valuation concerns and high options volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. ($DJT) is experiencing significant trading activity following its announced merger with fusion energy firm TAE Technologies in a deal valued at over $6 billion. This strategic pivot into the highly speculative fusion energy sector, with aspirations to power the AI boom, has ignited polarized community discussions, with supporters bullish on its long-term potential as an early publicly traded fusion play, while critics remain skeptical, viewing it as a speculative event.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending after announcing a substantial 10-year colocation agreement for its North Carolina AI data center campus with Nscale. This significantly valued contract is seen by the community as a pivotal development, expected to accelerate revenue growth and capitalize on the company's low public float within the rapidly expanding AI infrastructure market.

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Athira Pharma Inc

Athira Pharma is experiencing a significant surge and massive trading volume following its announcement of exclusively licensing a late-stage breast cancer drug program and securing substantial financing. This strategic pivot into oncology has ignited strong community discussion, with many anticipating further upside and a potential short squeeze, while others remain cautious of typical biotech volatility and the risks of profit-taking or dilution.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as a cooler-than-expected US CPI report fuels anticipation of Fed rate cuts, with some investors expecting this to boost long-duration bonds. However, community discussion is divided, with others highlighting persistent inflation concerns, aggressive government spending, and global liquidity shifts from the Bank of Japan as factors that could keep yields elevated. Despite the mixed outlook, significant institutional interest and a substantial short position are contributing to the ETF's active trading.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is trending as the community reacts to a recent presidential executive order signaling a potential reclassification of cannabis to Schedule III. While the stock experienced a significant dip, long-term investors are actively discussing the immense benefits this move could bring, particularly the removal of the 280E tax burden, which is anticipated to transform profitability for U.S. multi-state operators.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, Sunset, and Asset Closure. The Retail segment sells electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Sunset segment includes generation plants with announced retirement plans. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as power demand surges, notably from AI data centers, with the recent PJM Capacity Auction clearing at elevated prices which is expected to significantly increase revenue. Despite some recent price volatility causing frustration among investors, many remain highly bullish, viewing VST as a crucial energy play poised for substantial growth due to critical electricity shortages and ongoing grid challenges.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

ShapeShift FOX Token is trending as the community eagerly anticipates an imminent breakout from a prolonged downtrend, with many actively accumulating at current levels. Enthusiasts highlight FOX's exceptionally low market cap and strong fundamentals compared to major decentralized exchange competitors, fueling expectations of a substantial rally and "super cycle" as broader market conditions improve. The token's potential for significant upside is a key talking point among holders who believe it's currently undervalued.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is experiencing extreme volatility and a sharp sell-off, primarily driven by widespread forecasts for unseasonably warm weather which are dampening immediate natural gas demand. The community is fiercely divided, with some anticipating a strong rebound from oversold conditions, while others emphasize the inherent decay of this leveraged ETF and the persistence of mild winter outlooks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SurgePays (NASDAQ:SURG) Director Buys $61,475.20 in Stock

SurgePays, Inc. (NASDAQ:SURG - Get Free Report) Director David Allen May purchased 38,422 shares of SurgePays stock in a transaction that occurred on Wednesday, December 10th. The stock was acquired...

SurgePays (NASDAQ:SURG) Posts Earnings Results, Misses Estimates By $0.21 EPS

SurgePays (NASDAQ:SURG - Get Free Report) announced its quarterly earnings results on Wednesday. The medical equipment provider reported ($0.38) earnings per share (EPS) for the quarter, missing...

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million

SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026 Revenue Guidance of $225 Million SurgePays Announces Sequential Revenue Growth of Over 60% for Q3 and Affirms 2026...

SurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue Estimates

SurgePays, Inc. (SURG) delivered earnings and revenue surprises of -16.13% and -32.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Porch Group, Inc. (PRCH) Reports Break-Even Earnings for Q2

Porch Group (PRCH) delivered earnings and revenue surprises of +100.00% and +10.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

SurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue Estimates

Shares of nano-cap SurgePays, Inc. (SURG) jumped on Wednesday after the telecom and fintech company issued an upbeat outlook after announcing subpar annual results.The Barlett, Tennessee-based company reported a loss of $2.39 per share and revenue of $60.88 million for the year ended Dec. 31. This compares to the year-ago earnings per share (EPS) of $1.45 and revenue of $137.14 million.&nbsp;SurgePays blamed the predicament on the end of the federally funded Affordable Connectivity Program (ACP).The ACP is a U.S. government-sponsored program administered by the Federal Communications Commission (FCC) that provides affordable internet access to low-income households. The program stopped accepting applications in the first half of 2024, with April 2024 being the last fully-funded month.Even so, the company&nbsp;was upbeat about&nbsp;its outlook. “However, strategic investments made during this transition — including AT&amp;T integration, POS growth, and the development of our MVNE platform — have built the foundation for 2025's goal to return to growth and profitability,” it said.&nbsp;Brian Cox, Chairman and CEO, said, "We built the infrastructure. Now we are scaling. With AT&amp;T integration complete and LinkUp Mobile launching nationally, SurgePays is positioned for the most aggressive revenue growth phase in our history."LinkUp Mobile is the company’s retail prepaid wireless brand.Looking ahead, the company expects&nbsp;over $200 million in revenue over the next 12 months and positive cash flow from operations before the end of 2025, following the successful integration and official launch with AT&amp;T.&nbsp;The revenue guidance for the year is markedly above the Finchat-compiled consensus of $95.11 million.&nbsp;On Stocktwits, retail sentiment toward SurgePays stock stayed ‘extremely bullish’ (100/100) and the message volume spurted to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:637/137;" src="https://news.stocktwits-cdn.com/surg_sentiment_png_b7d7d166fb.webp" alt="surg-sentiment.png" width="637" height="137"><figcaption>SURG sentiment and message volume March 26, as of 12:54 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>A bullish watcher positioned for a multi-day run and predicted a move to $3 on Thursday.<stembedurl>https://stocktwits.com/Harunkaraca/message/609306748</stembedurl>Another user attributed his bullish sentiment to the moving average convergence divergence (MACD) indicator crossing over.<stembedurl>https://stocktwits.com/BananaExpress15/message/609287406</stembedurl><a href="https://stocktwits.com/symbol/SURG">SurgePays stock</a> soared by over 54% to $2.13 on Wednesday afternoon. The stock is down about 22.5% this year. If the gains are sustained, the stock is on track to finish with the biggest one-day gain in four years.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/playtika-receives-double-upgrade-from-bofa/chJbRWxRb3l">Playtika Stock On Track To Record Biggest Single-Day Gain Ever After BofA’s Double Upgrade: Retail’s Exuberant</a>

Rising stock market chart on a trading board background.

SurgePays Stock Surges As Strong Guidance Overshadows FY24 Underperformance: Retail Anticipates Multi-Day Run  

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.

Equity

 CEO Brian Cox said the company is positioned for the most aggressive revenue growth phase in its history.


This Week’s Hottest Themes: Biotech (RFK Jr. Meddling), Space (Trump's Space Force),&nbsp; AI (The Theme of the Year)&nbsp;WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in sectors actively drawing capital. This targeted approach, combined with real-time news surveillance, helps us uncover stocks poised for powerful multi-day or multi-month moves—often long before Wall Street analysts catch on.Here's a list of today's most important names:1. Cassava Sciences (NASDAQ: SAVA)Background: Cassava Sciences is a clinical-stage biotechnology company focused on Alzheimer’s disease. Its investigational drug, Simufilam, has been central to its research efforts.The News: Cassava's stock took a dramatic plunge after disappointing Phase 3 trial results for Simufilam, followed by a social media storm triggered by Martin Shkreli’s scathing critique of the drug’s efficacy. Shkreli, calling Simufilam’s mechanism “implausible,” encouraged short-sellers, predicting a sharp decline in the stock. The failure of the trial and Shkreli’s influence sent shares tumbling by more than 85%, from nearly $30 per share to under $5.What It Means: This setback emphasizes the significant risks in Alzheimer's drug development. With most Alzheimer’s trials failing, investors now question the credibility of Cassava’s lead drug. While the company still has resources to pivot, the stock’s credibility has been deeply shaken, and the road ahead is uncertain.Stock Reaction: Yesterday the stock opened at $30 but closed near $5, reflecting a swift and steep sell-off. The market’s reaction shows how quickly investor sentiment can turn negative on biotech stocks, particularly in high-risk, high-reward sectors like Alzheimer’s treatment.&nbsp;2. Poseida Therapeutics (NASDAQ: PSTX)Background: Poseida is a biopharmaceutical company specializing in gene therapies, particularly CAR-T treatments for cancer.The News: Poseida announced a significant partnership with Roche, securing $110 million upfront and up to $1 billion in potential milestones. This deal is aimed at accelerating Poseida's CAR-T therapies and other cell and gene therapy technologies.What It Means: This collaboration is a major validation for Poseida’s technology, especially in the competitive CAR-T space, which has attracted attention due to its potential to treat cancers. The cash infusion from Roche is expected to fuel further research and development.Stock Reaction: Poseida opened at $9.26, up over 200%, rising slightly to close at $9.38. The market responded favorably to the news, viewing the Roche deal as a solid indication of Poseida’s future potential in the cancer treatment landscape.&nbsp;3. KULR Technology Group (NYSE: KULR)Background: KULR specializes in thermal management technologies for energy storage and aerospace.The News: KULR Technology Group has received a U.S. Navy contract to develop its Internal Short Circuit (ISC) technology to operate at higher temperatures. This upgrade is important for both military and commercial applications, especially in aviation where it aligns with safety standards. The ISC devices, originally developed with NASA and NREL, simulate controlled thermal runaway in lithium-ion cells for more accurate and safer testing of battery behavior in extreme conditions.What It Means: The Navy contract could serve as a major stepping stone for KULR, providing the company with exposure to one of the most demanding industries for thermal solutions. This deal not only enhances KULR’s credibility but may also open doors for similar partnerships in the aerospace and defense sectors.Stock Reaction: The stock opened at $0.80 and climbed another 20% reaching $0.96 by mid-morning on volume that is 1,000%+ higher than average.&nbsp;4. POET Technologies (NASDAQ: POET)Background: POET is a leader in photonics technology, designing advanced semiconductor solutions aimed at AI, telecommunications, and data storage.The News: POET Technologies (NASDAQ: POET) is ramping up production of its optical engines to meet the increasing demand from AI applications. A recent report highlighted that while many companies in the UK are adopting AI, few have integrated it into their manufacturing processes, which could hinder innovation and productivity. The report suggests that government support and regulations could help accelerate AI adoption in industries.What It Means: As AI applications continue to expand, POET’s new platform could be a game-changer. The optical interposer aims to address the bottlenecks in data processing by enabling faster, more efficient communication between chips, which is crucial for AI and big data.Stock Reaction: POET opened at $4.38 and rose to $5.35 (up 22%) by mid-day on volume 3x higher than average.&nbsp;5. SurgePays (NASDAQ: SURG)Background: SurgePays provides financial services and prepaid wireless solutions for underserved markets.The News:&nbsp;SurgePays (SURG) has integrated its ClearLine marketing platform with PAX smart payment terminals, allowing merchants to deliver real-time promotions and offers during transactions. This integration leverages existing hardware to enhance customer engagement and streamline marketing efforts, helping retailers boost loyalty and sales. SurgePays aims to scale its retail presence by utilizing PAX's wide reach in the payment terminal industry.What It Means: SurgePays continues to capitalize on the significant need for affordable financial services and wireless solutions in underserved communities. This strong performance suggests the company’s business model is scaling effectively, positioning it well for future growth.Stock Reaction: SurgePays opened at $2.00 and surged to $2.20, up 10%, trading average volume.&nbsp;6. TOYO Ventures Holdings (NASDAQ: TOYO)Background: TOYO Co., Ltd. is a solar solutions company focused on becoming a full-service provider in the global market. It integrates all stages of the solar power supply chain, including wafer and silicon production, solar cell manufacturing, and photovoltaic module production. TOYO is positioned to produce high-quality solar cells at a competitive scale and cost.The News: TOYO Co., Ltd (Nasdaq: TOYO) has secured a $150 million contract to supply high-efficiency solar cells to a major solar module manufacturer. The agreement will support solar module production in India and the U.S., leveraging TOYO’s advanced manufacturing capabilities in Vietnam and Ethiopia. This contract highlights the company's commitment to sustainable energy and the global shift towards renewable resources.What It Means: The $150 million contract is a major win for TOYO Co., Ltd, solidifying its role as a key player in the solar energy sector. It highlights the company’s advanced manufacturing capabilities and global reach, particularly in India and the U.S. For the market, the deal signals continued growth in the solar industry, boosting confidence in renewable energy technologies and potentially attracting more investment. TOYO’s expanded presence in key markets could strengthen its competitive position as demand for efficient solar cells rises..Stock Reaction: Shares opened at $5.56, up 39% to retrace to $4.50 by mid-morning and closing at $5.41 on eye-poping 1,500x average volume.&nbsp;&nbsp;7. Anavex Life Sciences (NASDAQ: AVXL)Background:&nbsp;Anavex Life Sciences develops treatments for neurodegenerative disorders like Alzheimer's and Parkinson's. Its lead drug, ANAVEX®2-73, has shown positive results in Phase 2 trials, while the company is also developing ANAVEX®3-71 for Alzheimer's.The News:Anavex Life Sciences has submitted a Marketing Authorization Application (MAA) for its drug, blarcamesine (ANAVEX®2-73), to the European Medicines Agency (EMA) for the treatment of Alzheimer’s disease. Blarcamesine, an orally administered small molecule, showed significant clinical improvement in patients over 48 weeks, with better efficacy than approved therapies and a slower rate of neurodegeneration in early Alzheimer's patients. Its safety profile eliminates the need for routine MRI monitoring, making it a promising treatment option.What It Means:&nbsp;The MAA submission for blarcamesine to the EMA is a positive development for Anavex Life Sciences, potentially boosting its stock if approved. If successful, blarcamesine could open new revenue streams and strengthen investor confidence. For the broader market, this signals progress in Alzheimer’s treatment, potentially drawing more investment into biotech, especially in neurodegenerative diseases.Stock Reaction: Anavex opened at $10.30 up 10% from Monday's close, but cratered almost 20% from that high by mid-afternoon closing nearly flat from the previous day's close on slightly higher than average volume.&nbsp;&nbsp;Be The First to Know:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/newsletter-sign-up/">Our email list eats first! Get exclusive alerts on explosive stock picks like AST&nbsp;SpaceMobile (NASDAQ: ASTS) which shot up&nbsp;+533% after our profile. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here.</a>&nbsp;&nbsp;<hr>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/WealthyVC">Follow us on Twitter</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.instagram.com/wealthyventurecapital/">Follow us on Instagram</a> <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/TheWealthyVentureCapitalist/?locale=zh_CN">Follow us on Facebook</a><a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion in the WVC Facebook Investor Group</a>Have a Stock Tip or New&nbsp; Story Suggestion? Email us at Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

SurgePays, Inc. operates as a technology-driven company, which focuses on building a supply chain software platform as an alternative to traditional wholesale supply chain distribution models. It offers goods and services direct to convenience stores, bodegas, minimarts, tiendas and other corner stores, providing goods and services primarily to the underbanked community. The company was founded on August 18, 2006 and is headquartered in Bartlett, TN.

Surgepays Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.03	--	--	N/A
Q3 '25	-$0.14	-$0.38	-162.07%	MISSED
Q2 '25	-$0.19	-$0.36	-84.62%	MISSED
Q1 '25	-$0.35	-$0.38	-7.55%	MISSED
Q4 '24	-$0.25	-$1.07	-332.32%	MISSED

SURG
Surgepays Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SURG News

SURGSurgepays Inc